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Abstract
Background: Approximately 10 % of the Mycobacterium tuberculosis genome is made up of two families of genes that
are poorly characterized due to their high GC content and highly repetitive nature. The PE and PPE families are typified
by their highly conserved N-terminal domains that incorporate proline-glutamate (PE) and proline-proline-glutamate (PPE)
signature motifs. They are hypothesised to be important virulence factors involved with host-pathogen interactions, but
their high genetic variability and complexity of analysis means they are typically disregarded in genome studies.
Results: To elucidate the structure of these genes, 518 genomes from a diverse international collection of clinical isolates
were de novo assembled. A further 21 reference M. tuberculosis complex genomes and long read sequence data were
used to validate the approach. SNP analysis revealed that variation in the majority of the 168 pe/ppe genes studied was
consistent with lineage. Several recombination hotspots were identified, notably pe_pgrs3 and pe_pgrs17. Evidence of
positive selection was revealed in 65 pe/ppe genes, including epitopes potentially binding to major histocompatibility
complex molecules.
Conclusions: This, the first comprehensive study of the pe and ppe genes, provides important insight into M. tuberculosis
diversity and has significant implications for vaccine development.
Background
Tuberculosis disease (TB) is a major global public health
problem, with control becoming difficult due to increasing
drug resistance and in some populations HIV co-infection
[1]. The available vaccine, Bacillus Calmette–Guérin
(BCG), has limited efficacy and recent attempts to develop
more effective protective vaccines have not been success-
ful [2]. TB is caused by bacteria of the Mycobacterium
tuberculosis complex, which have low overall genetic di-
versity and a striking clonal population structure. M. tuber-
culosis sensu stricto consists of seven lineages, including
four that are predominant; 1 Indo-Oceanic, 2 East-Asian
including Beijing, 3 East-African-Indian, 4 Euro-American
[3]. These lineages are postulated to have differential im-
pacts on pathogenesis, disease outcome and vaccine efficacy
[4–7]. For example, modern lineages, such as Beijing and
Euro-American Haarlem strains exhibit more virulent phe-
notypes compared to ancient lineages, such as East African
Indian8. Whilst some genetic differences between lineages
have been identified3, the molecular mechanisms respon-
sible for differences in pathogenesis and virulence remain
largely unknown [8].
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Two groups of proteins, the PE and PPE families have
been implicated in immune evasion and virulence [9].
Members of the pe/ppe gene families are characterized
by the presence of proline-glutamate (PE) and proline-
proline-glutamate (PPE) signature motifs near the N-
terminus of their gene products [10]. The pe (99 loci)
and ppe (69) gene families constitute ~7–10 % of the
coding potential of M. tuberculosis and are scattered
throughout the genome [9]. The families can be subdi-
vided based on similarities in their N-terminal regions
[11]. Many of the pe and ppe gene products are pre-
dicted to be localised to the cell membrane or secreted
including those in the PE_PGRS domain containing sub-
group and the PPE_MPTR domain containing subgroup
[12, 13]. It has been speculated that these proteins may
play a role in virulence [14]. Pe/ppe genes are differen-
tially expressed during infection [15] and some PE/PPE
proteins have been shown to elicit immune responses by
the host [14, 16] and there is evidence that the PGRS
domain can inhibit antigen processing [16, 17].
Whilst pe_pgrs and ppe_mptr genes represent some of
the most variable M. tuberculosis regions, some mem-
bers of the pe/ppe family are conserved across strains
and species, therefore implying different functional roles.
Only the protein structures of PE25 and PPE41 have
been characterised [18], and in lieu of experimental
and functional work, insights into their function and
interaction partners must come from in silico analysis
of large-scale ‘omics data. However, due to the repeti-
tive nature and high GC content genetic variation in
the pe/ppe genes, it has been difficult to characterize
them using traditional mapping approaches, leading to
their systematic exclusion from analysis [18]. There
have been conflicting studies reporting either high or
little or no sequence divergence [19–21], but studies
have been limited by the number of genes and diver-
sity of strains analysed.
There is a need to fully characterize pe/ppe family se-
quence diversity across strain-types to provide better un-
derstanding of these genes and their possible role in
virulence and immune evasion. The availability of high
throughput short sequencing technologies has revolu-
tionized the study of M. tuberculosis genetic diversity. In
an attempt to characterize these elusive genes we have
performed whole genome assembly on next generation
sequence data with a high depth of coverage across the
pe/ppe gene regions from 518 clinical and experimental
isolates. These isolates represent the four major line-
ages, each with known informative barcoding SNPs [3].
The approach was validated by examination of 21 refer-
ence genomes from established databases (www.tbdb.org;
www.ebi.ac.uk), including 2 new strains with complete
genomes sequenced using long read Pacific Bioscience
(PacBio) technology [22, 23].
Results
Assembly of M. tuberculosis genomes
Conventional alignment-based analysis approaches have
been of limited use in analysis of highly repetitive loci,
including the pe/ppe genes. Here, we de novo assembled
the genomes of 518 samples from 9 different countries
covering the four main lineages (1 (n = 42), 2 (n = 38), 3
(n = 53), and 4 (n = 385)), with high sequence cover-
age in pe/ppe genes (mean 233-fold, range 100–1544)
(Additional file 1: Tables S1 and S2). For each sample, at
least 120 of the 168 pe/ppe genes were fully assembled
and at least 90 % assembled for the remaining 48 genes
(Additional file 1: Table S3). This level of assembly quality
ensured low levels of assembly fragmentation and mini-
mised poor gene characterization. Subsequent analysis
involving manual inspection or re-mapping of reads to the
assemblies using REAPR software, revealed all genes
(168 pe/ppe; 3,654 other genes; 2,820 with an assigned
function) to be of high quality (median REAPR score of
1 across all bases, reflecting high levels of accuracy in gen-
ome assemblies). A further 21 independent complete ref-
erence genomes representing all four lineages (Additional
file 1: Table S1), were aligned against H37Rv to call vari-
ants, and used to further validate the results found in the
assembled dataset.
Variant detection and population genetic analysis
A total of 50,539 genome-wide SNPs were identified by
comparing the 518 assembled genomes to the H37Rv
(lineage 4, Euro-American T) reference strain. Of
these, 5,853 (11.6 %) SNPs were located within pe/ppe
regions, with greater density than the rest of the
genome (median SNPs per kb: ppe/pe = 12.9, non-ppe/
pe = 9.1, Wilcoxon P < 2.2 × 10−14). In the 257 Malawi
samples, our assembly procedure revealed 3,467 add-
itional SNP variants genome-wide (1,438 (41.5 %)
SNPs in 72 pe/ppe genes) compared to the standard
approach of aligning short reads to the H3Rv refer-
ence. Of the 50,539 SNPs inferred from the assemblies,
the majority (45,681, 90.3 %) were located in coding
regions from all genes and consisted of 28,235 (61.8 %)
non-synonymous SNPs and 17,446 (38.2 %) synonym-
ous SNPs. This observation is in agreement with the
higher abundance of non-synonymous mutations re-
ported in the literature [19]. A large number of rare
variants (i.e. present in only one isolate) were observed
in all lineages, indicative of purifying selection and popula-
tion expansion described by others [24]. The peaks in the
spectrum represent a number of SNPs that are fixed in all
isolates from sub-lineages (Additional file 2: Figure S1).
The ratio of non-synonymous to synonymous muta-
tions was similar in pe/ppe and other genes (median:
pe/ppe genes = 1.65, other genes = 1.75, Wilcoxon P =
0.68). The density of non-synonymous mutations was
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2.98 times greater in pe/ppe genes compared to others
(pe/ppe genes: 1 every 3933 bp, other genes: 1 every
11,706 bp, Wilcoxon P < 0.0001), consistent with an-
other report [25]. When analysed by sub-family we ob-
served the greatest ratio of densities in the pe_pgrs
genes (pe_pgrs 3.89) compared to the other types (ppe
1.75, pe (non-pe_pgrs) 1.80), similar to that reported previ-
ously [25]. The nucleotide diversity (π) was ~2-fold greater
in the pe/ppe genes (median: pe/ppe genes 2.7 × 10−4,
other genes 1.4 × 10−4, Wilcoxon P < 1.4 × 10−10). Al-
though estimates of genetic diversity may be influ-
enced by sampling bias, nucleotide diversity varied by
lineage, being greater in lineage 1 (Indo-Oceanic me-
dian: pe/ppe 1.7 × 10−4, other 9.0 × 10−5) and lower in
lineage 2 (East-Asian median: pe/ppe 7.3 × 10−5, other 0)
(Additional file 1: Table S2), all consistent with previous
work [3]. Loci identified as being highly diverse (π > 0.003,
top 0.2 %, Table 1, Fig. 1), included 5 pe/ppe genes
(pe_pgrs3, pe_pgrs4, ppe57, ppe59 and ppe60), and 3
others (Rv0030, Rv0095c and lppB). The diversity per gene
was compared to those from 21 complete reference
genomes, and peaks were observed at Rv0095c, pe_pgrs3,
pe_pgrs4, ppe57 and ppe60, independently supporting five
out of the eight loci identified in the 518 global samples
(Additional file 3: Figure S2).
Phylogenetics
To examine the link between genetic variation and
lineage, a phylogenetic tree was constructed using the
50,539 SNPs. It revealed clustering by lineage, thereby
further validating the quality of the assembled genomes
(Additional file 4: Figure S3). However, a similar analysis
using 5,853 pe/ppe specific SNP positions led to a tree
with lineage 2 being split into two distinct clades, sur-
rounded by lineage 4 strains (Fig. 2a). Subsequent ana-
lysis using SNP-based population differentiation FST and
site-specific log likelihood scores approaches (Additional
file 5: Figure S4) revealed that the pe_pgrs3 gene (gen-
omic position 333 kb, lineage 2 – 104 SNPs differentiat-
ing) was predominantly responsible for the ambiguity.
Removal of the 281 SNPs in the pe_pgrs3 gene led to a
pe/ppe-based tree that clustered by lineage (Fig. 2b), very
similar in topology to that based on the genome-wide
SNPs (Additional file 4: Figure S3). This demonstrated
that a core set of pe/ppe SNPs appears to be lineage spe-
cific, and further analysis revealed a set of 87 (1.4 %) SNPs
(66 non-synonymous) that were lineage specific, poten-
tially forming the basis of a lineage-specific molecular bar-
code (Additional file 1: Table S4). None of these 87
mutations were present in M. bovis (GCA_000195835) or
M. africanum (NC_015758.1) sequences, and therefore
Table 1 Loci that are highly diverse, with recombination, or under selective pressure
Gene Locus No. SNPs Diversity π phi p-value phi p-valuea dN/dS (w) No. sitesb Lineage specific phi
Rv0030 Rv0030 3 0.0033 1.000 1.000 - 0 -
Rv0095c Rv0095c 10 0.0059 0.005 0.021 10.13 3 -
Rv0182c sigG 3 0.0003 0.046 0.046 - 0 -
Rv0278c pe_pgrs3 130 0.0193 <0.001 <0.001 10.5 49 1,3,4
Rv0279c pe_pgrs4 49 0.0035 0.001 0.419 10.5 20 -
Rv0282 eccA3 5 0.0005 0.007 0.210 9.697 6 -
Rv0850 Rv0850 2 0.0031 1.000 1.000 9.264 4 -
Rv0978c pe_pgrs17 9 0.0005 0.003 1.000 10.495 9 -
Rv1148c Rv1148c 18 0.0022 <0.001 0.015 10.492 5 4
Rv1793 esxN 6 0.0023 0.034 0.159 9.694 2 4
Rv1945 Rv1945 18 0.0010 <0.001 0.026 10.433 5 -
Rv2048c pks12 80 0.0008 <0.001 0.012 10.5 79 4
Rv2543 lppA 8 0.0015 0.006 0.002 10.036 5 4
Rv2544 lppB 60 0.0123 <0.001 <0.001 5.336 33 1,2,4
Rv3425 ppe57 31 0.0154 0.431 1.000 10.5 21 -
Rv3429 ppe59 19 0.0041 <0.001 0.084 10.419 29 4
Rv3466 Rv3466 6 0.0010 0.004 0.373 7.757 3 -
Rv3478 ppe60 105 0.0061 <0.001 0.004 7.502 54 4
Rv3619c esxV 3 0.0022 0.025 1.000 10.391 2 -
π nucleotide diversity, phi recombination, NS not significant
aafter removing sites under selection
bnumber of sites under selection using the Bayes Empirical Bayes method
Bolded refers to π > 0.003 or phi p-value < 0.05
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robust as M. tuberculosis lineage-specific markers. Using
only the pe_pgrs3 SNPs led to a tree with two large clades
(Additional file 6: Figure S5), one containing H37Rv and
strains with similar sequence, and the other consistent
with isolates similar to M323 and 18b strains (Additional
file 1: Table S1b), both undergoing recent sequencing
using PacBio long read technology. The M323, 18b and
similarly clustered assembled samples have a pe_pgrs3
gene with conserved regions at both 3′ and 5′ ends, sur-
rounding a highly similar hypervariable core. A different
hypervariable core is present in H37Rv and similarly clus-
tered assemblies, which interestingly is also present in the
pe_pgrs4 gene of 18b, and recombination is a potential
explanation.
Recombination detection
Although it has been thought that M. tuberculosis under-
goes little or no homologous recombination, PE_PGRS
and PPE_MPTR families contain long domains comprised
of series of tandem repeats, giving them a higher propen-
sity to undergo recombination. There is published evi-
dence of intra-chromosomal cross-over ahead of a few
loci [9], including pe_pgrs3, pe_pgrs4, and ppe1 [26]. We
hypothesized that recombination may be the reason for
the observed high genetic diversity and distortion in the
pe/ppe tree. We applied the pairwise homoplasy index
(phi) method [27] genome-wide to establish if there was
any evidence of recombination in pe_pgrs3 and other loci
(Fig. 3). The method calculates a p-value (phi P) of observ-
ing the sequence data under the null hypothesis of no
recombination. The analysis revealed 16 genes with poten-
tial recombination events (phi P < 0.05) present across
all lineages: 5 in pe/ppe genes (pe_pgrs3, pe_pgrs4,
pe_pgrs17, ppe59 and ppe60), and 11 others (Rv0095,
sigG, eccA3, Rv1148, esxN, Rv1945, pks12, lppA, lppB,
Rv3466 and esxV).
Fig. 1 Nucleotide diversity (π) across the genome by lineage; genes with high diversity (π > 0.003) are highlighted. The pe_pgrs3 gene appears to
have high nucleotide diversity in all lineages. Some lineage-specific hotspots are seen in lineage 1 (ppe59 and Rv3901c), lineage 3 (Rv2081c) and
lineage 4 (ppe57 and ppe60)
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Fig. 2 Phylogenetic tree constructed with SNPs. a pe/ppe genes (5,404 SNPs, 10 % of the genome); the pe_pgrs3 gene was identified as having
SNPs leading to the lineages not perfectly clustering, potential evidence of recombination affecting these loci. b pe/ppe genes excluding pe_pgrs3
(5,572 SNPs, ~10 % of the genome). Clear clustering according to lineage can be seen (Lineage 1 (Indo-Oceanic, green), lineage 2 (East-Asian (Beijing),
blue), lineage 3 (East-African-Indian, purple), lineage 4 (Euro-American, red)). Reference genomes are labelled. M. canetti is annotated in cyan
Fig. 3 Evidence of recombination at a gene level. A Manhattan plot showing genes that are likely to be recombination hotspots. The (−log10)
p-value for recombination is plotted against genome position. All genes with p-values <0.05 are labelled. Genes labelled in colour grey (eccA3,
pe_pgrs4, pe_pgrs17, ppe59, Rv3466 and esxV) become statistically non-significant after removing sites under selection
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It could be expected that the vast majority of any gen-
omic recombination events are intra-lineage and that
these events will pass unnoticed by other analyses, espe-
cially in studies of small sample size. Lineage-specific
hotspots were also present (Additional file 7: Figure S6),
including possible pathogenicity factors lppA/lppB in
lineage 2 (Beijing) and pe_pgrs3 in lineage 4. An analysis
of the 21 complete reference genomes revealed an over-
all high degree of concordance of the homoplasy phi
statistic with the assembled data, with six recombination
peaks in common (Rv0095c, pe_pgrs3, pe_pgrs4, pe_pgrs17,
Rv1148c and Rv1945) (Additional file 8: Figure S7). To-
gether, these results provide evidence for recombination.
Detecting selection pressure
It is possible that recombination and population expan-
sion [24] could have introduced not only the observed
increased diversity in the pe/ppe genes, but contributed
to an excess of non-synonymous mutation diversity in
general; especially in genes expected to be under positive
or diversifying selection such as the cell wall component
genes [24]. Proteins in contact with the host proteome
could be under pressure to change their amino acid se-
quence in order to avoid detection or unfavourable
interaction with the host immune system. We decided
to investigate the role of selection in the pe/ppe genes
compared to other categories of genes. The distribution
of dN/dS values (denoted ω, = 1 neutral evolution, >1
positive selection, <1 purifying selection), calculated for
each gene across all sites and branches of the phylogenetic
tree, was similar between pe/ppe and other genes (median
ω: pe/ppe genes 0.81, other genes 0.73; Wilcoxon P = 0.16).
These values are broadly similar to those previously
reported on much lower numbers of samples and pe/ppe
genes [25]. The genes were further divided into functional
Clusters of Orthologous Groups (COG) categories [28].
Higher median ω values were observed in genes associated
with signal transduction mechanisms (median = 0.95), per-
haps due to their contact with the host, and the lowest
values found in genes associated with RNA processing and
modification (median = 0.38) (Additional file 9: Figure S8).
In most genes it would be expected that only a small sub-
set of sites would undergo positive selection and so calcula-
tion of a single ω value over all sites in the gene may dilute
an effect. For example, this is possible in pe/ppe genes
where there is less variation in the N- compared to the C-
terminus [21]. We therefore used a likelihood ratio based
approach that accounts for the variability of ω between
sites. After implementation, we detected a greater propor-
tion of pe/ppe loci under positive selection compared to
other genes (ω > 1 and P < 0.05: pe/ppe genes 65 (39 %) vs.
other genes 590 (15 %)). This observation remained consist-
ent when the non-pe/ppe genes were subdivided into func-
tional categories (P-values for evidence of ω >1, Wilcoxon
P <0.001) (Fig. 4). Using the COG categories, the genes as-
sociated with cell motility and the pe/ppe genes again
showed greater evidence of significant positive selection
(Additional file 10: Figure S9). All genes annotated as pos-
sible recombination hotspots were identified as being under
positive selection, except Rv0182c. To localize the specific
polymorphisms under selection we applied the Bayes Em-
pirical Bayes (BEB) method [29], and identified a small
number of sites in each gene (median (range): pe/ppe genes
0 (0–60), other genes 0 (0–48), P = 1.2 × 10−10). In total 99
pe/ppe genes had sites under positive selection, including
ten genes with selection at more than ten sites (Additional
file 1: Table S5). For 1,106 non-pe/ppe genes, only 37 had
ten or more sites under positive selection. The proportion
of segregating sites under positive selection (Sp/Ss) per gene
was higher in the pe/ppe loci compared to others (pe/ppe
genes 0.04, other genes 0.00, Wilcoxon P = 2.58 × 10−7).
There was a correlation between the number of positively
selected and segregating sites (Pearson’s r, pe/ppe 0.81, and
other genes 0.32).
We considered the 3,686 sites in the 1,106 non-pe/ppe
genes with some evidence of positive selection (ω > 1).
These sites were compared to a list of drug resistance-
conferring mutations (www.tbdb.org), which because of a
survival advantage may be expected to be under positive
selection. Eighteen drug resistance markers were found,
including in inhA (I21T, S94A, I194T, P251A; associated
with the drug isoniazid), katG (S315T; isoniazid), gyrA
(A90V; fluoroquinolones), rpoB (P45L, rifampicin), rpoL
(K43R; rifampicin), and ponA1 (P631S; rifampicin). Other
regions of interest included rodA (T336S) involved in cell
wall processes and required for survival in primary murine
macrophages, and pks6 (V504L) involved in lipid metabol-
ism and in vitro growth. Repeating the recombination de-
tection analysis after removing the sites under positive
selection identified by the BEB method, revealed six genes
that lost their statistical significance (phi P > 0.05, eccA3,
pe_pgrs4, pe_pgrs17, ppe59, Rv3466 and esxV), leaving 10
as crossover hotspots (Fig. 3). Given that variation in these
genes is not caused by positive selection it is highly likely
that recombination hotspots are indeed present at these
ten loci. The proportion of sites under selection was high
for lppA (7 %) and lppB (43 %) loci. The BEB method
identified 38 codons in lppA/B at which ω > 1, with almost
all the related mutations present in lineage 2 (East-Asian)
samples. None of these codons were in previously de-
scribed conserved positions [30], implying that the core
function of the protein was not disturbed, and the muta-
tions may contribute to antigenic variation.
Selection on epitopes
Epitopes potentially binding to major histocompatibility
complex molecules were predicted in all PE/PPE pro-
teins using the netMHCpan software (Additional file 1:
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Table S6). The number of epitopes varied by pe/ppe gene
(median 45, range 0 – 455). Some pe/ppe sites identified
as being under selection using the BEB approach did
overlap with regions predicted to be epitopes. In particu-
lar, for 10 genes (pe6, pe_pgrs26, pe18, pe_pgrs49,
pe_pgrs60, ppe27, ppe57, ppe59, ppe60 and ppe65), more
than 20 % of predicted epitopes had sites under positive
selection (Additional file 1: Table S6).
Discussion
Members of the PE/PPE family of proteins have been
found to trigger innate immune responses, are targets of
the adaptive immune system, and potentially a rich
source of diagnostic and vaccine antigens. As large ‘omic
studies in M. tuberculosis have often excluded pe/ppe
genes from analysis (e.g. [3]), the understanding of their
function and diversity is poor compared to other loci.
Assessing diversity across M. tuberculosis strain types is
critical, as lineages may vary in propensity to transmit and
cause disease. By applying a de novo assembly approach,
we were able to characterize accurately nearly all 168
pe/ppe genes in 518 isolates with high genomic coverage,
representing lineages 1 (Indo-Oceanic), 2 (East-Asian), 3
(East-African-Indian) and 4 (Euro-American). After identi-
fying ~50 k genome-wide SNPs from whole genome align-
ments, we confirmed that pe/ppe genes, especially the
pe_pgrs family, have a high density of non-synonymous
mutations compared to other M. tuberculosis loci. This ob-
servation is consistent with their involvement in antigenic
variation and immune evasion, where proteins that are dir-
ectly exposed to host immune surveillance tend to show
higher levels of polymorphism. A lower degree of poly-
morphism in the ppe genes (compared to pe_pgrs) is likely
to reflect a strong functional constraint of the PPE
proteins.
Using all SNPs in a phylogenetic analysis, we observed
clustering by M. tuberculosis lineage and therefore
consistency with other published topologies [3, 31]. There
was evidence of lineage specific pe/ppe repertories, with a
very similar phylogeny being attained by restricting ana-
lysis to all polymorphisms in 167 PE/PPE genes (excluding
pe_pgrs3), as well as a derived subset of 87 informative
SNPs. The pe_pgrs3 gene had high nucleotide diversity
across all lineages, was not lineage informative, and is
likely to be have been subject to recombination in lineages
1, 3 and 4. BothM. bovis and M. canetti contain two genes
Fig. 4 Evidence of positive selection between the pe/ppe and other genes by functional annotation. Distributions of (−log10) p-values for positive
selection (evidence of ω >1) across the pe/ppe and other genes by functional annotation
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annotated as orthologues of pe_pgrs3, providing further
evidence towards the propensity of this region to undergo
genomic rearrangements. Interestingly the positioning of
the M. tuberculosis reference strains in the pe/ppe gene
phylogenetic tree was altered; some strains clustering near
the M. canetti and ancestral strains while some of the
known virulent reference strains were positioned at a fur-
ther distance. Further study is needed to elucidate this ef-
fect. Other recombination and diversity hotspots included
lppB (lineages 1, 2, and 4) and ppe60 (lineage 4) genes,
both known to have undergone homologous recombin-
ation. LppB (and lppA) are non-essential exported lipopro-
teins that are unique to pathogenic mycobacteria and may
encode antigens [32, 33]. The lppA/B SNPs driving this ef-
fect were found mostly in lineage 2 (Beijing) strains, and
seemed to be conferring a selective advantage. The role of
lppA/B proteins on virulence should be investigated fur-
ther. Although, pe_pgrs17, whose protein is in contact
with the host immune system [34], was identified as a re-
combination hotspot, this observation may be confounded
by positive selection. However, recombination has been
described in pe_pgrs17, with large numbers of SNPs and
indels in the pe_pgrs17 and pe_pgrs18 pair observed across
the different lineages, potentially arising from gene con-
version events [35]. We can rule out the results being con-
founded due to a sampling frame that included different
geographical regions, as there was strongest clustering by
lineage and not geographical source.
Across all M. tuberculosis genomes there was evidence
that most genes were undergoing purifying selection
pressures (dN/dS < 1). However, the pe/ppe genes were
most likely to be under positive selection (dN/dS > 1),
consistent with some PE/PPE proteins providing anti-
genic variation. It is possible the dN/dS ratios may be
underestimated, as the methodology is more appropriate
to divergent species and not for comparisons within a
population [25]. Further, the signatures from very local-
ised regions of selection within a gene may be diluted by
surrounding genetic variation. A site-specific analysis con-
firmed the results from the gene-based dN/dS. Whilst the
majority of the sixty-five genes identified as being under
positive selection had only a single positively selected site,
a disproportionate number of pe_pgrs genes had multiple
positively selected sites. A potential limitation of this ana-
lysis is the time dependence of dN/dS for closely related
bacterial genomes. This leads to possible over-estimation
of the dN/dS and difficulties in interpretation when com-
paring the strength of selection between genes, genomes
or populations over very short time-scales [36]. The power
of the dN/dS statistic to detect positive selection is
reduced when samples come from a single population
[25]. In addition to the site under selection, multiple
neighbouring and linked sites may show evidence of selec-
tion due to hitchhiking effects.
Our findings provide potential insights into the use of
PE/PPE proteins as vaccine components. The high levels
of polymorphism observed and the lineage-specific na-
ture in certain members of these protein families could
limit their effectiveness. A PE/PPE protein that displays
higher sequence conservation across many strains may
be a more effective vaccine candidate. For example, the
highly immunogenic PE_PGRS62 protein has been con-
sidered as a vaccine target [37], and as only one of the
14 non-synonymous mutations observed was lineage
specific, it may have broad strain coverage. However,
one roadblock is the limited immunogenicity data avail-
able at the pe/ppe epitope level. It has been found that
human T-cell epitopes are highly conserved in the M.
tuberculosis complex [38], and like others [25] we found
many epitopes predicted in PE/PPE proteins. Our ana-
lysis revealed a number of pe/ppe genes with a high pro-
portion of epitopes potentially subjected to diversifying
or positive selection. As these epitopes may be used by
M. tuberculosis to evade the host immune system they
would be relevant for TB vaccination strategies.
A cohesive understanding of the function of the 168
PE/PPE family of proteins remains elusive. By analysing
SNP variation in 518 samples across the four main M.
tuberculosis lineages we identified pe/ppe genes that are
highly diverse, recombination hotspots and under positive
selection. Such analyses can assist with prioritising candi-
dates for functional studies, potentially leading to TB con-
trol measures, such as vaccines, diagnostics and drugs.
Conclusions
Human tuberculosis poses a major burden on health ser-
vices worldwide. There is a need to understand the com-
plex interactions between the human host and bacterial
pathogen so that new control measures, such as vaccines
and drugs, can be developed. Recent technological ad-
vances have allowed large-scale studies to determine the
genetic signatures of strain-types or ancestral lineages
and drug resistance outcomes. Despite this advance,
some highly variable regions of the genome are often ex-
cluded [39, 40]. This includes the pe/ppe gene family,
whose members are thought to interact with the human
immune system, but little is still known of their diversity
and function. Here we present the first comprehensive
study of the genetic diversity of the 168 pe/ppe genes.
We find most genes vary in a lineage specific manner,
consistent with strain-specific repertories. However, there
were exceptions to this pattern, with evidence of some
genes undergoing genetic cross-over events. Further, by
looking for the genes under selective pressure genome-
wide, we found enrichment in the number of pe/ppe genes
undergoing positive selection. Overall, our work highlights
the importance of pe/ppe genes, describes their suitability
as vaccine candidates, and provides the basis for further
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exploration of the proteins involved in the host immune
system and pathogen interactions.
Methods
The raw sequencing fastq files for 518M. tuberculosis sam-
ples with more than 100-fold genomic coverage were
sourced from the PolyTB [41], rapid TB [42] and global
drug resistance (Coll F, McNerney R, Hill-Cawthorn G et
al. Whole genome association analysis of a global collection
of Mycobacterium tuberculosis clinical isolates gives new
insight into drug resistance, Submitted) projects (Additional
file 1: Table S1a). A list of ENA accession numbers is avail-
able for download (http://pathogenseq.lshtm.ac.uk/ppe).
Lineages were inferred using robust barcoding SNPs [3].
Lineages 1, 2, 3 and 4 were represented with 42, 38, 53 and
385 samples from each respectively (Additional file 1: Table
S2). A separate set of twenty-one samples representing line-
ages 1 to 4 with complete or near complete genomes were
used for validation (Additional file 1: Table S1b). In particu-
lar, all analyses performed on the main 518 samples were
also applied to the validation dataset in an attempt to con-
firm signals and potentially rule out spurious findings. As-
sembly of all short reads was performed using MaSuRCA,
SGA, Velvet and SPAdes [43–46] software, run in paired
end mode with default and recommended parameters,
across multiple k-mer values ranging from 31 to 91.
The final Velvet run was implemented with a k-mer
value of 63. Quast [47] software was used to extract
assembly quality metrics using the H37Rv strain
(Gene bank: AL123456) as the reference. The Samtools
rmdup utility [48] was used to remove duplicates from each
sample’s BAM file, and picard SamToFastq (http://broadin-
stitute.github.io/picard/) was used to convert the BAM files
to fastq format. IMAGE software [49] was used to close
gaps from the contigs produced by Velvet. After running
IMAGE for 3 iterations using a k-mer size of 55, the num-
ber of pe/ppe genes assembled increased for all samples,
especially in high coverage samples. The majority (range:
78–98 %) of gaps were closed within 3 iterations, which
provided a threshold to justify the compromise between
runtime and gaps closed in new contigs (fasta format).
REAPR software was used to assess the quality of the as-
semblies, and calculates a quality score per base (http://
www.sanger.ac.uk/science/tools/reapr reapr). The final as-
semblies are available for download (http://pathogen-
seq.lshtm.ac.uk/ppe). The pe/ppe and other genes were
called by aligning the assemblies to the well annotated
H37Rv genome. The 50,539 SNPs genome-wide were
identified using nucmer [50] with H37Rv as the reference
genome. To assess the robustness of the aligned sequences
and resulting SNPs and analyses, we also mapped samples
to a Mycobacterium africanum lineage reference (GCA_
000253355.1), but observed no major differences from
those using H37Rv (lineage 4). Phylogenetic data
(alignments, phylogenetic trees) are deposited in Dryad
(http://datadryad.org/).
The alignments of the genotypes for the 50,539 SNPs
formed the basis of the majority of population genetic
analyses, except where stated otherwise. SNP locations
at which more than 10 % of the genotypes were missing
were excluded from analyses. Other missing data was
kept in the multiple alignments and was processed ac-
cording to the default settings of the analysis software
applied. Indels were identified by nucmer but were not
analysed in this study. Regions where multiple contigs
overlapped or where no contigs mapped to were anno-
tated as missing data. FastTree [51] software employing
the generalised time-reversible model was used to pro-
duce the final phylogenetic trees. The trees included
the ancient M. canettii strain (NC_019950.1). The FST
measure was calculated for each SNP to identify
markers with complete between-lineage allele differen-
tiation (FST >0.99). Similarly, the ancestral recon-
structed sequence for the lineage-defining node in the
phylogenetic tree was compared with its closest ances-
tral node, and the SNP differences derived. Nucleotide
diversity (π) and the number of segregating sites were
calculated using variscan software applied to sequence
alignments [52]. To test for recombination we used the
pairwise homoplasy index (phi) statistic calculated in
sliding windows, as implemented in Phipack software
[27]. The non-synonymous to synonymous ratio was
calculated using PAML software [53]. To discover the
effect of positive selection on the pe/ppe genes compared
to all other genes, codeml was used to fit a number of
models to the data using a maximum likelihood approach.
This is generally thought to be more robust than counting
methods. A dN/dS (ω) value was calculated per gene across
all positions and all branches of the phylogenetic tree. For
each gene, we then performed a likelihood ratio test using
PAML software to assess evidence of positive selection,
which compared two models: (a) variable selective pressure
but no positive selection (0 <ω < 1) (M8a) and (b) variable
selective pressure with positive selection (M8) (ω > 1). The
test statistic has a χ2 (1 degree of freedom) distribution,
and the resulting p-value reflects the likelihood of positive
selection acting on a gene. To localize the specific poly-
morphisms under selection we applied the Bayes Empirical
Bayes (BEB) method [29]. The proportion of segregating
sites under positive selection (Sp/Ss) was calculated using
the results from variscan and BEB. Epitopes were predicted
using netMHCpan [54] using HLA alleles previously sug-
gested [21].
No ethical approvals were required for this study.
Availability of supporting data
The list of raw sequence data accession numbers for the
ENA short read archive, final assemblies and links to the
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phylogenetic data (alignments, phylogenetic trees) in Dryad
can be found in http://pathogenseq.lshtm.ac.uk/ppe.
Additional files
Additional file 1: Table S1. a) The samples used for the assembly
(*Malawi [55, 56], Netherlands [57], Pakistan [58], Portugal [59]) and b)
the 21 reference strains. Table S2. Lineage, sequence coverage and
polymorphism. π nucleotide diversity; Lineage 1 Indo-Oceanic; Lineage 2
East-Asian (Beijing); Lineage 3 East-African-Indian; Lineage 4 Euro-
American. Table S3. Completeness of pe/ppe gene assemblies. Table S4.
List of 87 pe/ppe lineage specific-markers. S synonymous, NS non-
synonymous, * genes bolded if there are sites under selection using the
Bayes Empirical Bayes method; Lineage 1 Indo-Oceanic; Lineage 2 East-
Asian (Beijing); Lineage 3 East-African-Indian; Lineage 4 Euro-American.
Table S5. Genes with more than 10 sites under selective pressure (dN/dS
(ω) >1). Table S6. Epitopes. * identified using netMHCpan, ** epitopes
that had sites under positive selection according to the Bayes Empirical
Bayes (BEB) method. (DOCX 70 kb)
Additional file 2: Figure S1. Allele frequency spectra for each lineage
by synonymous (blue) and non-synonymous (red) mutations. The peaks
at intermediate allele frequencies include sub-lineage defining SNPs
(Lineage 1 Indo-Oceanic; Lineage 2 East-Asian (Beijing); Lineage 3 East-
African-Indian; Lineage 4 Euro-American). (TIF 207 kb)
Additional file 3: Figure S2. Gene-based nucleotide diversity (π) for
the 21 reference genomes. All genes with high nucleotide diversity
(π > 0.0075) are labelled. (TIF 148 kb)
Additional file 4: Figure S3. Phylogenetic tree constructed using
50,540 genome-wide SNPs. Clear clustering according to lineage can be
seen (Lineage 1 (Indo-Oceanic, green), lineage 2 (East-Asian (Beijing), blue),
lineage 3 (East-African-Indian, purple), lineage 4 (Euro-American, red)).
Reference genomes are labelled. M. canetti is annotated in cyan. (TIF 69 kb)
Additional file 5: Figure S4. Identifying sites leading to differences in
tree topologies based on all SNPs (Additional file 4: Figure S3a) and only
those from pe/ppe genes (Additional file 4: Figure S3b). The Δ Site wise
log likelihood score (Δ SSLS) is calculated for each SNP in the pe/ppe
gene alignments. Negative differences indicate SNP positions favouring
the pe/ppe tree. SNPs in pe_pgrs3, ppe57 and ppe60 produce strong
phylogenetic signals supporting the pe/ppe tree. (TIF 113 kb)
Additional file 6: Figure S5. Phylogenetic tree created using only
SNPs from pe_pgrs3. No clear clustering by lineage is observed. However
there are two major clades, one consistent with H37Rv (bottom-left).
(TIF 126 kb)
Additional file 7: Figure S6. Lineage-specific recombination hotspots.
Manhattan plots showing genes that are likely to be recombination
hotspots in each lineage (Lineage 1 Indo-Oceanic; Lineage 2 East-Asian
(Beijing); Lineage 3 East-African-Indian; Lineage 4 Euro-American). The
(−log10) p-value for the phi statistic is plotted against genome position.
All genes with p-values < 0.05 are labelled. (TIF 147 kb)
Additional file 8: Figure S7. Evidence of recombination at a gene level
in the 21 reference genomes. A Manhattan plot showing genes that are
likely to be recombination hotspots. The (−log10) p-value for the phi
statistic is plotted against genome position. Genes with p-values less than
0.05 are shown. (TIF 120 kb)
Additional file 9: Figure S8. Selection dN/dS values for each gene
within Clusters of Orthologous Groups (COG*) categories. *ppe/N = pe/ppe
genes annotated as COG category N, * COG categories: A RNA processing
and modification, B Chromatin Structure and dynamics, C Energy
production and conversion, D Cell cycle control and mitosis, E Amino
Acid metabolism and transport, F Nucleotide metabolism and transport, G
Carbohydrate metabolism and transport, H Coenzyme metabolism, I Lipid
metabolism, J Translation, K Transcription, L Replication and repair, M Cell
wall/membrane/envelope biogenesis, N Cell motility, O Post-translational
modification, protein turnover, chaperone functions, P Inorganic ion
transport and metabolism, Q Secondary Structure, T Signal Transduction,
U Intracellular trafficking and secretion, Y Nuclear structure, Z Cytoskeleton,
R General Functional Prediction only, S Function Unknown. (TIF 124 kb)
Additional file 10: Figure S9. Non-neutral evolution for genes within
Clusters of Orthologous Groups (COG*) categories. Boxplots are
constructed using (-log10) p-values of non-neutral evolution for each
gene. *ppe/N = pe/ppe genes annotated as COG category N, * COG
categories: A RNA processing and modification, B Chromatin Structure
and dynamics, C Energy production and conversion, D Cell cycle control
and mitosis, E Amino Acid metabolism and transport, F Nucleotide
metabolism and transport, G Carbohydrate metabolism and transport,
H Coenzyme metabolism, I Lipid metabolism, J Translation, K Transcription,
L Replication and repair, M Cell wall/membrane/envelope biogenesis, N Cell
motility, O Post-translational modification, protein turnover, chaperone
functions, P Inorganic ion transport and metabolism, Q Secondary Structure,
T Signal Transduction, U Intracellular trafficking and secretion, Y Nuclear
structure, Z Cytoskeleton, R General Functional Prediction only, S Function
Unknown. (TIF 127 kb)
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